- 0.03 (1.07%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
|Recent News Releases|
Eyenovia Prices Public Offering of Common Stock
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability
|There are currently no events scheduled.|